Pediatric Experimental Therapeutics

Learn about the Pediatric Experimental Therapeutics Program at Penn State Children’s Hospital Pediatric Oncology. 

For more information, call


Pediatric Experimental Therapeutics Program

Our Pediatric Experimental Therapeutics Program began in 2010. Its mission is to offer new, experimental treatments that incorporate leading-edge science to children with all types of cancer, including solid tumors, leukemias and lymphomas. 

We’re able to offer a variety of clinical trials to our patients through our memberships in the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC), the Pediatric Oncology Experimental Therapeutics Investigators’ Consortium (POETIC), the Pediatric Blood and Marrow Transplant Consortium (PBMTC) and the Children’s Oncology Group (COG).

The Pediatric Experiment Therapeutics Program is lead by our Experimental Therapeutics Research and Clinical Team (ExTRaCT):